Thomas Carell

Scientific Advisor at STORM Therapeutics

Thomas Carell (Ph. D) was raised in Bad-Salzuflen (Germany). He studied chemistry at the Universities of Münster and Heidelberg. In 1993 he obtained his doctorate with Prof. H. A. Staab at the Max Planck Institute of Medical Research in Heidelberg. After postdoctoral training with Prof. J. Rebek at MIT (Cambridge, USA) in 1993-1995, Thomas Carell moved to the ETH Zürich (Switzerland) as an assistant professor to start independent research. He obtained his habilitation (tenure) in 2000. He subsequently accepted a full professor position for Organic Chemistry at the Philipps-Universität in Marburg (Germany). In 2004 Thomas Carell moved to the Ludwig-Maximilians-Universität (LMU) in Munich (Germany), where he is heading a research group centered around chemical biology. The current focus is to analyze the chemistry of epigenetics and prebiotic chemistry. Thomas Carell is a founder of the company Baseclick GmbH. He is a member of the National German Academy, Leopoldina and of the Berlin-Brandenburg Academy of Arts and Sciences. Thomas Carell received the Cross of Merit from the Federal Republic of Germany (knighted). Thomas Carell obtained the Leibniz award and an ERC advanced grant. He is the speaker of the Excellence Cluster (EXC114) on protein chemistry and of the collaborative research center (SFB13ß9) on Chemical Epigenetics.